Login / Signup

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.

Andrei NikiforchinVadim GushchinMary Caitlin KingEkaterina BaronCarol NierodaMichelle SittigArmando Sardi
Published in: Journal of surgical oncology (2021)
CRS/HIPEC at a nonacademic center with advanced surgical and auxiliary services is a safe option to treat PSM with favorable surgical and oncological outcomes.
Keyphrases